Page 40 - MEGIN Book Of Abstracts - 2023
P. 40

Biomarkers for autism spectrum disorder:           IDD subpopulations who share a common disease
            opportunities for magnetoencephalography (MEG)     pathway, and thus identify individuals with IDD who
            (2021)                                             might ultimately benefit from specific treatments.
                                                               After briefly demonstrating the need and potential for
                          Roberts, Timothy P L; Kuschner, Emily S; Edgar, J   scope, examples from studies examining brain func-
            Christopher                                        tion and structure in children with autism spectrum
                                                               disorder (ASD) illustrate how measures of brain neuro-
            Dept. of Radiology, Lurie Family Foundations MEG Imaging   nal function (from magnetoencephalography, MEG),
            Center, Children's Hospital of Philadelphia, 3401 Civic Center   brain structure (from magnetic resonance imaging,
            Blvd., Philadelphia, PA, 19104, USA. [email protected]  MRI, especially diffusion MRI), and brain chemistry
                                                               (MR spectroscopy) can help us better understand the
            ABSTRACT This paper reviews a candidate biomarker   heterogeneity in ASD and form the basis of multivariate
            for ASD, the M50 auditory evoked response compo-   biological markers (biomarkers) useable to define clini-
            nent, detected by magnetoencephalography (MEG)     cal subpopulations. Similar approaches can be applied
            and presents a position on the roles and opportunities   to understand brain dysfunction in neurodevelopmen-
            for such a biomarker, as well as converging evidence   tal disorders (NDD) in general. In large part, this paper
            from allied imaging techniques (magnetic resonance   represents our endeavors as part of the CHOP/Penn
            imaging, MRI and spectroscopy, MRS). Data is pre-  NICHD-funded intellectual and developmental disabili-
            sented on prolonged M50 latencies in ASD as well as   ties research center (IDDRC) over the past decade.
            extension to include children with ASD with significant
            language and cognitive impairments in whom M50     Journal of neurodevelopmental disorders (2021), Vol. 13,
            latency delays are exacerbated. Modeling of the M50   No. 1 (34525943) (0 citations)
            latency by consideration of the properties of auditory
            pathway white matter is shown to be successful in typi-
            cal development but challenged by heterogeneity in   Atypical development of emotional face processing
            ASD; this, however, is capitalized upon to identify a dis-  networks in autism spectrum disorder from
            tinct subpopulation of children with ASD whose M50   childhood through to adulthood (2021)
            latencies lie well outside the range of values predict-
            able from the typically developing model. Interestingly,                         Safar, Kristina; Vandewouw, Marlee M; Taylor, Margot J
            this subpopulation is characterized by low levels of
            the inhibitory neurotransmitter GABA. Following from   Diagnostic Imaging, Hospital for Sick Children, Toronto,
            this, we discuss a potential use of the M50 latency in   Canada; Neurosciences and Mental Health Program, Re-
            indicating "target engagement" acutely with adminis-  search Institute, Hospital for Sick Children, Toronto, Canada.
            tration of a GABA-B agonist, potentially distinguishing   Electronic address: [email protected]; Diagnostic
            "responders" from "non-responders" with the implica-  Imaging, Hospital for Sick Children, Toronto, Canada; Neu-
            tion of optimizing inclusion for clinical trials of such   rosciences and Mental Health Program, Research Institute,
            agents. Implications for future application, including   Hospital for Sick Children, Toronto, Canada; Autism Research
            potential evaluation of infants with genetic risk factors,   Center, Bloorview Research Institute, Holland Bloorview
            are discussed. As such, the broad scope of potential of   Kids Rehabilitation Hospital, Toronto, Canada; Institute
            a representative candidate biological marker, the M50   of Biomedical Engineering, University of Toronto, Toronto,
            latency, is introduced along with potential future appli-  Canada; Diagnostic Imaging, Hospital for Sick Children,
            cations.This paper outlines a strategy for understand-  Toronto, Canada; Neurosciences and Mental Health Pro-
            ing brain dysfunction in individuals with intellectual   gram, Research Institute, Hospital for Sick Children, Toronto,
            and developmental disabilities (IDD). It is proposed that   Canada; Department of Psychology, University of Toronto,
            a multimodal approach (collection of brain structure,   Toronto, Canada; Department of Medical Imaging, University
            chemistry, and neuronal functional data) will identify   of Toronto, Toronto, Canada







             ontents         Index                       19
               C
   35   36   37   38   39   40   41   42   43   44   45